STOCK TITAN

CVRx (NASDAQ: CVRX) CRO gets new stock awards, sells shares for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

CVRx, Inc. Chief Revenue Officer John Robert Allen reported a mix of stock sales and awards. He sold 3,964 shares of common stock in an open-market transaction at a weighted average price of $7.9025 per share to cover tax withholding obligations from equity awards. He also received a grant of 35,000 restricted stock units and 52,000 stock options, both vesting over several years starting on February 27, 2027, increasing his long-term equity exposure to the company.

Positive

  • None.

Negative

  • None.

Insights

Routine equity grants paired with a tax-related share sale.

The transactions show John Robert Allen receiving 35,000 restricted stock units and 52,000 stock options, both with multi‑year vesting schedules starting on February 27, 2027. These awards increase his potential future ownership if performance and tenure conditions are met.

He sold 3,964 common shares at a weighted average of $7.9025 per share in a sell‑to‑cover transaction mandated by the award agreement to satisfy tax withholding. This is characterized as a tax-related sale rather than a discretionary reduction in exposure, and overall appears as routine compensation and withholding activity.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
John Robert Allen

(Last) (First) (Middle)
9201 WEST BROADWAY AVENUE
SUITE 650

(Street)
MINNEAPOLIS MN 55445

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Revenue Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/27/2026 A 35,000(1) A $0 90,000 D
Common Stock 03/02/2026 S(2) 3,964 D $7.9025(3) 86,036 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $8.16 02/27/2026 A 52,000 (4) 02/26/2036 Common Stock 52,000 $0 52,000 D
Explanation of Responses:
1. Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.
2. The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.
3. Reflects the weighted average price of 3,964 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.994 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
4. Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.
/s/ Amy C. Seidel, Attorney-in-Fact 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did CVRX Chief Revenue Officer John Robert Allen report?

John Robert Allen reported selling 3,964 CVRX common shares and receiving two new equity awards. He was granted 35,000 restricted stock units and 52,000 stock options, both vesting over time, increasing his potential long-term ownership in CVRx, Inc. subject to vesting conditions.

Why did John Robert Allen sell 3,964 shares of CVRX stock?

The 3,964-share sale was mandated by CVRx’s award agreement to satisfy tax withholding obligations through a sell-to-cover transaction. This means shares were sold automatically to cover taxes arising from his equity awards, rather than as a discretionary portfolio sale.

What equity awards did John Robert Allen receive from CVRX?

He received 35,000 restricted stock units and 52,000 stock options in CVRx, Inc. The restricted stock units vest 25% on each annual anniversary of the grant date, while the options vest over four years beginning in 2027, aligning compensation with long-term company performance.

How do John Robert Allen’s new CVRX restricted stock units vest?

The restricted stock units vest as to 25% of the shares on each annual anniversary of the grant date. This schedule provides four annual vesting tranches, encouraging multi-year service and alignment with CVRx’s long-term business results and share performance over time.

What is the vesting schedule for John Robert Allen’s new CVRX stock options?

The stock options vest 25% of the shares on February 27, 2027, then 1/48th of the shares each month thereafter. This creates a four-year monthly vesting pattern, gradually increasing his exercisable options as he continues service with CVRx, Inc.

At what price were John Robert Allen’s CVRX shares sold in the tax-related transaction?

The 3,964 CVRX shares were sold at a weighted average price of $7.9025 per share. Individual sale prices ranged from $7.90 to $7.994 per share, across multiple transactions on March 2, 2026, as part of the mandated tax withholding process.
Cvrx, Inc.

NASDAQ:CVRX

CVRX Rankings

CVRX Latest News

CVRX Latest SEC Filings

CVRX Stock Data

220.23M
23.95M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MINNEAPOLIS